Jafron Biomedical Overview
- Year Founded
-
1989
- Status
-
Public
- Employees
-
2,797
- Stock Symbol
-
300529
- Share Price
-
$3.15
- (As of Monday Closing)
Jafron Biomedical General Information
Description
Jafron Biomedical Co Ltd is a China-based company engaged in the research, development, production, and sales of biomaterials and medical devices. It offers solutions for kidney disease, poisoning, rheumatic immune solution, critical illness and liver disease. The company's products include JFYC-100 pre-punching machine, DX-10 blood purifier, and HA resin hemoperfusion.
Contact Information
Website
www.jafron.comCorporate Office
- Number 98 Technology Six Road
- High-tech Zone
- Zhuhai, Guangdong 519085
- China
Corporate Office
- Number 98 Technology Six Road
- High-tech Zone
- Zhuhai, Guangdong 519085
- China
Jafron Biomedical Stock Performance
As of 14-Jul-2025, Jafron Biomedical’s stock price is $3.15. Its current market cap is $2.52B with 799M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.15 | $3.15 | $2.88 - $5.59 | $2.52B | 799M | 6.66M | $0.13 |
Jafron Biomedical Financials Summary
As of 31-Mar-2025, Jafron Biomedical has a trailing 12-month revenue of $344M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 2,713,748 | 3,053,924 | 2,394,759 | 3,462,453 |
| Revenue | 344,312 | 373,122 | 271,715 | 369,949 |
| EBITDA | 129,787 | 162,620 | 82,289 | 159,415 |
| Net Income | 100,513 | 114,306 | 61,696 | 132,090 |
| Total Assets | 782,432 | 737,449 | 782,002 | 785,086 |
| Total Debt | 193,991 | 189,926 | 236,282 | 184,938 |
Jafron Biomedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Jafron Biomedical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Jafron Biomedical ESG
Risk Overview
Risk Rating
Updated June, 15, 2025
31.09 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile
Healthcare
Industry
of 562
Rank
Percentile
Medical Devices
Subindustry
of 194
Rank
Percentile
Jafron Biomedical FAQs
-
When was Jafron Biomedical founded?
Jafron Biomedical was founded in 1989.
-
Where is Jafron Biomedical headquartered?
Jafron Biomedical is headquartered in Zhuhai, China.
-
What is the size of Jafron Biomedical?
Jafron Biomedical has 2,797 total employees.
-
What industry is Jafron Biomedical in?
Jafron Biomedical’s primary industry is Other Devices and Supplies.
-
Is Jafron Biomedical a private or public company?
Jafron Biomedical is a Public company.
-
What is Jafron Biomedical’s stock symbol?
The ticker symbol for Jafron Biomedical is 300529.
-
What is the current stock price of Jafron Biomedical?
As of 14-Jul-2025 the stock price of Jafron Biomedical is $3.15.
-
What is the current market cap of Jafron Biomedical?
The current market capitalization of Jafron Biomedical is $2.52B.
-
What is Jafron Biomedical’s current revenue?
The trailing twelve month revenue for Jafron Biomedical is $344M.
-
What is Jafron Biomedical’s annual earnings per share (EPS)?
Jafron Biomedical’s EPS for 12 months was $0.13.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
